- Q2 2024 Biora Therapeutics Inc Earnings Call TranscriptAug 12, 2024$0.5833 (-1.35%)Earnings
- Q1 2024 Biora Therapeutics Inc Earnings Call TranscriptMay 15, 2024$0.715 (-3.10%)Earnings
- Q4 2023 Biora Therapeutics Inc Earnings Call TranscriptMar 26, 2024$1.33 (+9.02%)Earnings
- Q3 2023 Biora Therapeutics Inc Earnings Call TranscriptNov 13, 2023$1.37 (-3.52%)Earnings
- Q2 2023 Biora Therapeutics Inc Earnings Call TranscriptAug 14, 2023$3.17 (-8.38%)Earnings
- Biora Therapeutics Inc Annual Shareholders Meeting TranscriptJun 14, 2023
- Q1 2023 Biora Therapeutics Inc Earnings Call TranscriptMay 15, 2023$3.35 (-10.90%)Earnings
- Q4 2022 Biora Therapeutics Inc Earnings Call TranscriptMar 30, 2023$2.67 (+0.75%)Earnings
- Biora Therapeutics Inc Extraordinary Shareholders Meeting TranscriptDec 19, 2022
- Q3 2022 Biora Therapeutics Inc Earnings Call TranscriptNov 14, 2022$7.03 (+0.75%)Earnings
- Q2 2022 Biora Therapeutics Inc Earnings Call TranscriptAug 15, 2022$26 (+4.00%)Earnings
- Biora Therapeutics Inc Annual Shareholders Meeting TranscriptJun 15, 2022
- Q1 2022 Biora Therapeutics Inc Earnings Call TranscriptMay 10, 2022$19.27 (+1.43%)Earnings
- Q4 2021 Progenity Inc Earnings Call TranscriptMar 28, 2022$40.25 (-4.73%)Earnings
- Q3 2021 Progenity Inc Earnings Call TranscriptNov 10, 2021$88 (+3.23%)Earnings
- Q2 2021 Progenity Inc Earnings Call TranscriptAug 12, 2021$43.5 (-3.87%)Earnings
- Progenity Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 22, 2021
- Progenity Inc Call to Discuss Strategic Transformation TranscriptJun 02, 2021
- Q1 2021 Progenity Inc Earnings Call TranscriptMay 13, 2021$58.75 (-1.67%)Earnings
- Q4 2020 Progenity Inc Earnings Call TranscriptMar 18, 2021$109.75 (-11.85%)Earnings
- Progenity Inc Preeclampsia Virtual R&D Day TranscriptNov 20, 2020
- Q3 2020 Progenity Inc Earnings Call TranscriptNov 09, 2020$121.75 (-0.20%)Earnings
- Q2 2020 Progenity Inc Earnings Call TranscriptAug 13, 2020$223.75 (-1.97%)Earnings
Q2 2022 Biora Therapeutics Inc Earnings Call Transcript
Greetings and welcome to the Biora Therapeutics second-quarter 2022 earnings call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Alexandra Schuman. Please go ahead.
Thank you, operator. Good afternoon, and welcome to Biora Therapeutics' second-quarter 2022 corporate update and financial results conference call. Joining me on the call are Adi Mohanty, Chief Executive Officer; and Eric d'Esparbes, Chief Financial Officer.
Before I turn the call over to Mr. Mohanty, I would like to remind you that today's call will include forward-looking statements within the meaning of the federal securities laws, including, but not limited to, the types of statements identified as forward-looking in our quarterly report on Form 10-Q that we will file later today and our subsequent reports filed with the SEC, which will all be available on our website in the Investors section.
These forward-looking statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)